AI Summary
We reviewed 32 live results for adalimumab and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Prescription Medicine and Medicine.
We reviewed 32 live results for adalimumab and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Prescription Medicine and Medicine.
Source: Bumrungrad International Hospital
Description
A biologic DMARD and TNF inhibitor used for patients with moderate to severe rheumatoid arthritis. Available as sterile solutions for injection (40 mg or 20 mg), it is often reserved for those who do not respond to conventional treatments.
Best for
advanced RA treatment, TNF inhibitor therapy, biologic DMARD access and patients failing conventional therapy
Rating
Source: Fresenius Kabi Philippines, Inc.
Description
Idacio is a citrate-free adalimumab biosimilar biologic medicine manufactured by Fresenius Kabi. Delivered as a 40 mg/0.8 mL solution for subcutaneous injection, it is available in prefilled pen (auto-injector) and prefilled syringe formats. It is indicated for treating chronic inflammatory conditions such as Rheumatoid Arthritis, Psoriatic Arthritis, Crohn’s Disease, and Ulcerative Colitis, providing a highly similar alternative to the reference product Humira.
Best for
rheumatoid arthritis treatment, inflammatory bowel disease therapy, citrate-free injection preference and adalimumab biosimilar therapy
Rating
Source: Amgen Inc.
Description
Amgevita is the international brand name for Amgen's adalimumab biosimilar, widely used in Canada, Europe, and New Zealand. It is indicated for the treatment of autoimmune diseases such as Hidradenitis Suppurativa, Uveitis, and juvenile idiopathic arthritis, alongside major inflammatory conditions. The product is available in convenient formats including single-use pre-filled pens and syringes.
Best for
international patients, uveitis treatment, hidradenitis suppurativa care and ankylosing spondylitis patients
Rating
| Compare | Adalimumab | Idacio (Adalimumab) | Amgevita (adalimumab) |
|---|---|---|---|
| Source | Bumrungrad International Hospital | Fresenius Kabi Philippines, Inc. | Amgen Inc. |
| Description | A biologic DMARD and TNF inhibitor used for patients with moderate to severe rheumatoid arthritis. Available as sterile solutions for injection (40 mg or 20 mg), it is often reserved for those who do not respond to conventional treatments. | Idacio is a citrate-free adalimumab biosimilar biologic medicine manufactured by Fresenius Kabi. Delivered as a 40 mg/0.8 mL solution for subcutaneous injection, it is available in prefilled pen (auto-injector) and prefilled syringe formats. It is indicated for treating chronic inflammatory conditions such as Rheumatoid Arthritis, Psoriatic Arthritis, Crohn’s Disease, and Ulcerative Colitis, providing a highly similar alternative to the reference product Humira. | Amgevita is the international brand name for Amgen's adalimumab biosimilar, widely used in Canada, Europe, and New Zealand. It is indicated for the treatment of autoimmune diseases such as Hidradenitis Suppurativa, Uveitis, and juvenile idiopathic arthritis, alongside major inflammatory conditions. The product is available in convenient formats including single-use pre-filled pens and syringes. |
| Best for | advanced RA treatment, TNF inhibitor therapy, biologic DMARD access and patients failing conventional therapy | rheumatoid arthritis treatment, inflammatory bowel disease therapy, citrate-free injection preference and adalimumab biosimilar therapy | international patients, uveitis treatment, hidradenitis suppurativa care and ankylosing spondylitis patients |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
If you want the most balanced option to start with, I recommend:
"Adalimumab from Bumrungrad International Hospital."
I picked this because A highly effective biologic option for advanced RA management available at premier private hospitals in Thailand.